KENILWORTH, N.J., March 9 /PRNewswire-FirstCall/ -- Schering-Plough Corporation will not present at the Barclays Capital Global Healthcare Conference in Miami, on Tuesday, March 10, as previously planned. We will be participating in various investor and employee communications related to the merger agreement with Merck announced earlier today, and therefore, will not be able to attend the conference.
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough’s vision is to “Earn Trust, Every Day” with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.
CONTACT: Media, Fred Malley, +1-908-298-7428, or Investors, Janet M. Barth
or Joe Romanelli, +1-908-298-7436, all of Schering-Plough Corporation
Web site: http://www.schering-plough.com/
